FDA-Drug2026-04-15Class IIPROCESSING DEFECT
Viatris Xanax XR 3 mg recalled for failed dissolution specifications
What this means
Viatris is recalling one lot of Xanax XR (alprazolam) 3 mg extended-release tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This affects only lot #8177156 with an expiration date of 02/28/2027, distributed nationwide. No injuries have been reported.
- Check if your Xanax XR 3 mg bottle has lot #8177156 and expiration date 02/28/2027
- If it matches, contact your pharmacy or prescriber before stopping the medication
- Do not stop taking alprazolam abruptly without medical guidance, as it can cause serious withdrawal symptoms
- Your pharmacist can verify the lot number on your bottle label
The agency's original wording
Hazard
Failed Dissolution Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide.
Manufactured in
1000 Mylan Blvd, Canonsburg, PA, United States
Products
Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0444-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.